Literature DB >> 36434

Polymorphonuclear leukocyte-mediated, antibody-dependent, cellular cytotoxicity against tumor cells: dependence on oxygen and the respiratory burst.

D G Hafeman, Z J Lucas.   

Abstract

Experiments were done to determine 1) whether the respiratory burst of superoxide anion (O2-) production in polymorphonuclear leukocytes (PMN) is triggered during antibody-dependent killing of tumor cells and 2) whether O2- production is essential for cytotoxicity. Three parameters of the respiratory burst (1-14C-glucose oxidation, oxygen consumption, and O2- release) were increased 2.5- to 7.3-fold during killing of antibody-primed tumor cells by human PMN. Added catalase and superoxide dismutase did not inhibit lysis, possibly because these enzymes were unable to diffuse into the inter-plasma-membrane space between killer and target cells. Evidence for an O2- requirement for cytotoxicity was the fact that concentrations of amobarbital or phenylbutazone sufficient to inhibit the cyanide-insensitive respiration of PMN also inhibited cytotoxicity. Also, hypoxic conditions inhibited cytotoxicity from 29 to 73%. The requirement for oxygen was most likely related to O2- generation and not mitochondrial respiration since cyanide and azide, which inhibit mitochondrial respiration, increased cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36434

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Relationship between antibody-dependent tumour cell lysis and primary granule exocytosis by human neutrophils.

Authors:  F Dallegri; G Frumento; A Ballestrero; R Goretti; F Patrone
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

2.  The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase.

Authors:  A R Cross; O T Jones
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

3.  Possible role of reactive forms of oxygen in in vitro killing of Schistosoma mansoni sporocysts by hemocytes of Lymnaea stagnalis.

Authors:  R Dikkeboom; C J Bayne; W P van der Knaap; J M Tijnagel
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

4.  Different activation pathways involved in antibody-dependent and immune-complexes-triggered cytotoxicity mediated by neutrophils.

Authors:  J R Geffner; M Giordano; G Serebrinsky; M A Isturiz
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

5.  Decreased luminol-dependent chemiluminescence response of neutrophils to recombinant human tumour necrosis factor in patients with gastric cancer.

Authors:  I A Schepetkin; N V Cherdyntseva; E V Borunov; I L Skutina; S A Naumov
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.

Authors:  T Ihara; S E Starr; M Ito; S D Douglas; A M Arbeter
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

7.  Activation of monocyte and granulocyte antibody-dependent cytotoxicity by phorbol myristate acetate.

Authors:  D K Klassen; P R Conkling; A L Sagone
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

8.  Oxygen dependence of human alveolar macrophage-mediated antibody-dependent cytotoxicity.

Authors:  P Conkling; G Papermaster-Bender; M Whitcomb; A L Sagone
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  Concanavalin A-induced chemiluminescence in rat thymus lymphocytes. Its origin and role in mitogenesis.

Authors:  D A Hume; K Wrogemann; E Ferber; M E Kolbuch-Braddon; R M Taylor; H Fischer; M J Weidemann
Journal:  Biochem J       Date:  1981-09-15       Impact factor: 3.857

10.  Cytochrome b co-fractionates with gelatinase-containing granules in human neutrophils.

Authors:  F Mollinedo; C Gajate; D L Schneider
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.